Evidence map›Paper›PMID 40715334›Full record

ArticleScientific reports2025

TRIM3 suppressed the tumorigenicity of melanoma cells by ubiquitinating YAP1.

Yi-Tong Wang, Jing-Chen Zhao, Ding-Ming Song, Jun-Jiang Chen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi-Tong WangDepartment of Burns and Plastic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Jing-Chen ZhaoDepartment of Burns and Plastic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Ding-Ming SongDepartment of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Jun-Jiang ChenDepartment of Burns and Plastic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. chenjunjiang211@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tripartite motif-containing 3 (TRIM 3), as a vital member of TRIM family, has been receiving significant attention in cancer research. This research aims to detect the effect and relevant molecular functions of TRIM3 in melanoma cells.GEPIA website and immunohistochemical analysis were performed to investigate TRIM3 level in melanoma samples. The growth ability, the mobility, and the apoptosis of M14 and A375 cells were determined by biological experiments. qPCR and western blot assays were performed to evaluate the expression of key genes. The interaction between TRIM3 and YAP1 was verified by immunoprecipitation and ubiquitination assays.A reduction of TRIM3 was observed in melanoma samples, and the loss of TRIM3 strengthened the proliferation and mobility of M14 and A375 cells and diminished apoptosis, and vice versa. TRIM3 expression only affected the protein level of YAP1, while YAP1 mRNA was not changed. Then, we demonstrated that TRIM3 directly interacted with YAP1, and TRIM3 reduced YAP1 stability by inducing ubiquitination modification. Finally, rescue assays showed that si-YAP1 treatment alleviated the effects of si-TRIM3 on melanoma cells.This study indicated that depletion of TRIM3 strengthened the proliferation and mobility of M14 and A375 cells, suppressed cell apoptosis, but these phenomena were counteracted by YAP1 down-regulation.

Indexed as

Adaptor Proteins, Signal TransducingCarrier ProteinsMelanomaTranscription FactorsApoptosisCarcinogenesisCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansTripartite Motif ProteinsUbiquitinationYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingCarrier ProteinsTranscription FactorsTRIM3 protein, humanTripartite Motif ProteinsYAP1 protein, humanYAP-Signaling ProteinsMelanomaTRIM3UbiquitinationYAP1

Identifiers

PMID40715334
PMCPMC12297579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.